title: Human immunodeficiency virus-infected patients undergoing liver transplantation are at high risk of vascular complications: true or not?
authors.forename: Umberto
authors.initials: U
authors.lastname: Baccarani
authors.forename: Stefania
authors.initials: S
authors.lastname: Bidinost
authors.forename: Marcello
authors.initials: M
authors.lastname: Tavio
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Viale
authors.forename: Gian Luigi
authors.initials: GL
authors.lastname: Adani
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000601:surgery*; D006801:Humans; D008107:Liver Diseases / Q000601:surgery* / Q000821:virology*; D016031:Liver Transplantation; D008297:Male; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents